The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Gadolinium‐based contrast agents for magnetic resonance cancer imaging
Open accessAbstract
Magnetic resonance imaging (MRI) is a clinical imaging modality effective for anatomical and functional imaging of diseased soft tissues, including solid tumors. MRI contrast agents (CA) have been routinely used for detecting tumor at an early stage. Gadolinium‐based CA are the most commonly used CA in clinical MRI. There have been significant efforts to design and develop novel Gd(III) CA with high relaxivity, low toxicity, and specific tumor binding. The relaxivity of the Gd(III) CA can be increased by proper chemical modification. The toxicity of Gd(III) CA can be reduced by increasing the agents' thermodynamic and kinetic stability, as well as optimizing their pharmacokinetic properties. The increasing knowledge in the field of cancer genomics and biology provides an opportunity for designing tumor‐specific CA. Various new Gd(III) chelates have been designed and evaluated in animal models for more effective cancer MRI. This review outlines the design and development, physicochemical properties, and in vivo properties of several classes of Gd(III)‐based MR CA tumor imaging. WIREs Nanomed Nanobiotechnol 2013, 5:1–18. doi: 10.1002/wnan.1198 This article is categorized under: Diagnostic Tools > Biosensing Diagnostic Tools > In Vivo Nanodiagnostics and Imaging
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design
Lauffer, R. B. (1987) · Chemical Reviews · doi:10.1021/cr00081a003 · Cited by 1,978
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H.-J. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,682
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Tumor Detection by Nuclear Magnetic Resonance
Damadian, R. (1971) · Science · doi:10.1126/science.171.3976.1151 · Cited by 1,466
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents
Caravan, P. (2006) · Chemical Society Reviews · doi:10.1039/b510982p · Cited by 1,438
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
Weinmann, H., Brasch, R., Press, W., & Wesbey, G. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.619 · Cited by 1,231
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Folic Acid: Nutritional Biochemistry, Molecular Biology, and Role in Disease Processes
Lucock, M. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3027 · Cited by 815
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
Wiener, E., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., & Lauterbur, P. C. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310102 · Cited by 718
Villaraza, A. J. L., Bumb, A., & Brechbiel, M. W. (2010) · Chemical Reviews · doi:10.1021/cr900232t · Cited by 632
Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging
Mulder, W. J. M., Strijkers, G. J., van Tilborg, G. A. F., Griffioen, A. W., & Nicolay, K. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1011 · Cited by 535
High‐Relaxivity MRI Contrast Agents: Where Coordination Chemistry Meets Medical Imaging
Werner, E. J., Datta, A., Jocher, C. J., & Raymond, K. N. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800212 · Cited by 463
Nano-sized MRI contrast agents with dendrimer cores
KOBAYASHI, H., & BRECHBIEL, M. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.016 · Cited by 437
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Current status of gadolinium toxicity in patients with kidney disease
Perazella, M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06011108 · Cited by 275
OGAN, M. D., SCHMIEDL, U., MOSELEY, M. E., GRODD, W., PAAJANEN, H., & BRASCH, R. C. (1987) · Investigative Radiology · doi:10.1097/00004424-198708000-00008 · Cited by 274
Saito, R., Bringas, J. R., McKnight, T. R., Wendland, M. F., Mamot, C., Drummond, D. C., Kirpotin, D. B., Park, J. W., Berger, M. S., & Bankiewicz, K. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3631 · Cited by 231
Gadofullerene MRI Contrast Agents
Bolskar, R. D. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.201 · Cited by 223
Magnetic resonance molecular imaging of the HER-2/neu receptor.
Artemov, D., Mori, N., Ravi, R. K., & Bhujwalla, Z. M. (2003) · PubMed · Cited by 217
Lansman, J. B. (1990) · The Journal of General Physiology · doi:10.1085/jgp.95.4.679 · Cited by 213
Konda, S. D., Aref, M., Wang, S., Brechbiel, M., & Wiener, E. C. (2001) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/bf02668091 · Cited by 210
Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application
Kobayashi, H., & Brechbiel, M. W. (2003) · Molecular Imaging · doi:10.1162/15353500200303100 · Cited by 202
Relaxivity Enhancement in Macromolecular and Nanosized GdIII‐Based MRI Contrast Agents
Botta, M., & Tei, L. (2012) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201101305 · Cited by 197
Low, Y. L. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0266-6 · Cited by 184
Gadolinium blocks low- and high-threshold calcium currents in pituitary cells
Biagi, B. A., & Enyeart, J. J. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.259.3.c515 · Cited by 183
Molecular magnetic resonance imaging with targeted contrast agents
Artemov, D. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10660 · Cited by 168
Kukowska‐Latallo, J. F. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2696 · Cited by 162
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds
Pilch, J., Brown, D. M., Komatsu, M., Järvinen, T. A. H., Yang, M., Peters, D., Hoffman, R. M., & Ruoslahti, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511219103 · Cited by 162
PAMAM Dendrimer Based Macromolecules as Improved Contrast Agents
Venditto, V. J., Regino, C. A. S., & Brechbiel, M. W. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050019e · Cited by 157
Kobayashi, H., Sato, N., Hiraga, A., Saga, T., Nakamoto, Y., Ueda, H., Konishi, J., Togashi, K., & Brechbiel, M. W. (2001) · Magnetic Resonance in Medicine · Cited by 141
Mamot, C., Nguyen, J. B., Pourdehnad, M., Hadaczek, P., Saito, R., Bringas, J. R., Drummond, D. C., Hong, K., Kirpotin, D. B., McKnight, T. R., et al. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000024743.56415.4b · Cited by 141
Folate Receptor Targeted Bimodal Liposomes for Tumor Magnetic Resonance Imaging
Kamaly, N., Kalber, T. L., Thanou, M., Bell, J. D., & Miller, A. D. (2009) · Bioconjugate Chemistry · doi:10.1021/bc8002259 · Cited by 139
Liposomal Gd-DTPA: preparation and characterization of relaxivity.
Tilcock, C., Unger, E. C., Cullis, P. R., & MacDougall, P. (1989) · Radiology · doi:10.1148/radiology.171.1.2928549 · Cited by 137
Paganelli, G., Bartolomei, M., Ferrari, M. E., Cremonesi, M., Broggi, G., Maira, G., Sturiale, C. L., Grana, C. M., Prisco, G., Gatti, M., et al. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780152389410 · Cited by 131
Sato, N., Kobayashi, H., Hiraga, A., Saga, T., Togashi, K., Konishi, J., & Brechbiel, M. W. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1314 · Cited by 130
Xu, H., Regino, C. A. S., Koyama, Y., Hama, Y., Gunn, A. J., Bernardo, M., Kobayashi, H., Choyke, P. L., & Brechbiel, M. W. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0701085 · Cited by 119
Langereis, S., de Lussanet, Q. G., van Genderen, M. H. P., Meijer, E. W., Beets‐Tan, R. G. H., Griffioen, A. W., van Engelshoven, J. M. A., & Backes, W. H. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1015 · Cited by 119
New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging
Ghaghada, K. B., Ravoori, M. K., Sabapathy, D. G., Bankson, J. A., Kundra, V., & Annapragada, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007628 · Cited by 114
Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy, J. A., Xu, L.-C., Parker, N. L., Vetzel, M., & Leamon, C. P. (2004) · PubMed · Cited by 113
Han, L., Li, J., Huang, S., Huang, R., Liu, S., Hu, X., Yi, P., Shan, D., Wang, X., Lei, H. C., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.005 · Cited by 107
Luo, K., Liu, G., She, W., Wang, Q., Wang, G., He, B., Ai, H., Gong, Q., Song, B., & Gu, Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.006 · Cited by 105
A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging
Hak, S., Sanders, H. M. H. F., Agrawal, P., Langereis, S., Grüll, H., Keizer, H. M., Arena, F., Terreno, E., Strijkers, G. J., & Nicolay, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.017 · Cited by 103
Storrs, R. W., Tropper, F. D., Li, H. Y., Song, C. K., Kuniyoshi, J. K., Sipkins, D. A., Li, K. C., & Bednarski, M. D. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00133a001 · Cited by 101
Magnetic Resonance Spectroscopy in Metabolic and Molecular Imaging and Diagnosis of Cancer
Glunde, K., Artemov, D., Penet, M., Jacobs, M. A., & Bhujwalla, Z. M. (2010) · Chemical Reviews · doi:10.1021/cr9004007 · Cited by 101
Ye, F., Jeong, E., Jia, Z., Yang, T., Parker, D., & Lu, Z. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800211r · Cited by 100
Self-citationMagnetic resonance in the era of molecular imaging of cancer
Gore, J. C., Manning, H. C., Quarles, C. C., Waddell, K. W., & Yankeelov, T. E. (2011) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2011.02.003 · Cited by 98
Bhujwalla, Z. M., Artemov, D., Natarajan, K., Solaiyappan, M., Kollars, P., & Kristjansen, P. E. G. (2003) · PubMed · Cited by 95
Real-time Imaging and Quantification of Brain Delivery of Liposomes
Krauze, M. T., Forsayeth, J., Park, J. W., & Bankiewicz, K. S. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9103-5 · Cited by 94
Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
Unger, E. C., Winokur, T. S., MacDougall, P., Rosenblum, J., Clair, M. R., Gatenby, R. A., & Tilcock, C. (1989) · Radiology · doi:10.1148/radiology.171.1.2928550 · Cited by 92
Daldrup-Link, H. E., Shames, D. M., Wendland, M. F., Okuhata, Y., Link, T. M., Rosenau, W., Lü, Y., & Brasch, R. C. (1998) · Pediatric Radiology · doi:10.1007/s002470050296 · Cited by 88
Wendland, M. F., Saeed, M., Yu, K. K., Roberts, T. P. L., Lauerma, K., Derugin, N., Varadarajan, J., Watson, A. D., & Higgins, C. B. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320307 · Cited by 88
Tan, M., Wu, X., Jeong, E., Chen, Q., & Lu, Z. (2010) · Biomacromolecules · doi:10.1021/bm901352v · Cited by 83
Self-citationGd‐DOTA Conjugate of RGD as a Potential Tumor‐Targeting MRI Contrast Agent
Park, J. A., Lee, J., Jung, J., Yu, D., Oh, C. H., Ha, S., Kim, T., & Chang, Y. (2008) · ChemBioChem · doi:10.1002/cbic.200800529 · Cited by 73
Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis
Huang, R., Han, L., Li, J., Liu, S., Shao, K., Kuang, Y., Hu, X., Wang, X., Lei, H. C., & Jiang, C. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.075 · Cited by 70
Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI
Lu, Z., Parker, D. L., Goodrich, K. C., Wang, X., Dalle, J. G., & Buswell, H. R. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10656 · Cited by 63
Self-citationRaatschen, H., SIMON, G. H., Fu, Y., Sennino, B., Shames, D. M., Wendland, M. F., McDonald, D. M., & Brasch, R. C. (2008) · Radiology · doi:10.1148/radiol.2472070363 · Cited by 59
Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging
Bui, T., Stevenson, J., Hoekman, J., Zhang, S., Maravilla, K. R., & Ho, R. J. Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013082 · Cited by 57
Contrast‐enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor‐bearing mice
Zong, Y., Wang, X., Goodrich, K. C., Mohs, A. M., Parker, D. L., & Lu, Z. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20402 · Cited by 55
Self-citationLu, Z., Mohs, A. M., Zong, Y., & Feng, Y. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.1.31 · Cited by 52
Self-citationImmunogenicity of Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging
BAXTER, A. B., MELNIKOFF, S., Stites, D. P., & Brasch, R. C. (1991) · Investigative Radiology · doi:10.1097/00004424-199112000-00001 · Cited by 46
Zinc Transmetallation and Gadolinium Retention after MR Imaging: Case Report
Greenberg, S. A. (2010) · Radiology · doi:10.1148/radiol.10100560 · Cited by 46
Dafni, H., Kim, S., Bankson, J. A., Sankaranarayanapillai, M., & Ronen, S. M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21727 · Cited by 34
Brain Tumor Enhancement in Magnetic Resonance Imaging at 3 Tesla
Fries, P., Runge, V. M., Bücker, A., Schürholz, H., Reith, W., Robert, P., Jackson, C. B., Lanz, T., & Schneider, G. K. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e31819817ff · Cited by 25
MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma
Karathanasis, E., Park, J., Agarwal, A., Patel, V., Zhao, F., Annapragada, A., Hu, X. P., & Bellamkonda, R. V. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/31/315101 · Cited by 21
Chemistry of Tumour Targeted T1 Based MRI Contrast Agents
Kamaly, N., Miller, A. D., & Bell, J. D. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791384199 · Cited by 21
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Intracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents
Ni, D., Bu, W., Ehlerding, E. B., Cai, W., & Shi, J. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00316a · Cited by 484
Yan, R., Hu, Y., Liu, F., Wei, S., Fang, D., Shuhendler, A. J., Liu, H., Chen, H.-Y., & Ye, D. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03649 · Cited by 389
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Zhou, Z., Qutaish, M., Han, Z., Schur, R. M., Liu, Y., Wilson, D. L., & Lu, Z.-R. (2015) · Nature Communications · doi:10.1038/ncomms8984 · Cited by 260
Self-citation
Metadata
- Authors
- Zhou, Z., & Lu, Z.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2012-10-09
- Volume
- 5
- Issue
- 1
- Pages
- 1-18
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W2033116451
- Cited by
- 427
- References
- 68
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.